Bamo 400 en es it fr

Bamo 400 Brand names, Bamo 400 Analogs

Bamo 400 Brand Names Mixture

  • No information avaliable

Bamo 400 Chemical_Formula


Bamo 400 RX_link

No information avaliable

Bamo 400 fda sheet

Bamo 400 msds (material safety sheet)

Bamo 400 Synthesis Reference

No information avaliable

Bamo 400 Molecular Weight

309.469 g/mol

Bamo 400 Melting Point

< 25 oC

Bamo 400 H2O Solubility

Soluble as HCl salt

Bamo 400 State


Bamo 400 LogP


Bamo 400 Dosage Forms

Tablets (oral, 1 mg)

Bamo 400 Indication

Used for the symptomatic treatment of parkinsonism.

Bamo 400 Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Bamo 400 Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Bamo 400 side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Bamo 400 Patient Information

Bamo 400 Organisms Affected

Humans and other mammals